Brief: Microba Life Sciences Posts H1 Revenue Of A$8.08M
29/01/2025 01:20
Jan 29 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* H1 FY25 REVENUE OF A$8.08M
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement